30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 15 Label Accuracy in Cannabinoid Products

This episode explores label accuracy in cannabinoid products, with a focus on the challenges and importance of proper labeling in the CBD/THC industry. The discussion covers research from JAMA showing widespread mislabeling issues, the potential dangers of inaccurate labels for consumers, and the critical role of third-party testing and cGMP compliance in ensuring product safety. The conversation also delves into lesser-known cannabinoids like CBG, CBN, and THCV, examining their unique properties and potential benefits.